🔎 Trials Near Me

Home › Sickle Cell Disease › Maryland

Pag-aaral pangklinika para sa Sickle Cell Disease sa Maryland

17 pag-aaral para sa Sickle Cell Disease ang naghahanap ng mga kalahok sa mga site sa Maryland.

Mga Lungsod sa Maryland

Opisyal na teksto ng pag-aaral (English)

Blood Sampling for Research Related to Sickle Cell Disease

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT00542230

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  • The Johns Hopkins University School of Medicine, Baltimore
Nagre-recruitPhase 3
Edad 12 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06439082

Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitMaagang Phase 1
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06313398

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT03937817

Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05170412

Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT05904093

Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaral
Edad 2 hanggang 99 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06944067

SCD Stem Cell Mobilization and Apheresis Using Motixafortide

  • National Heart, Blood and Lung Institute-Cellular and Molecular Therapy Branch, Bethesda
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06442761

Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 1/2
Edad 4 hanggang 65 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07599176

Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 1
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT07566494

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

  • Local Institution - 0064, Baltimore
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06481306

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Johns Hopkins University Hemophilia Treatment Center, Baltimore
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  • University of Maryland, Baltimore
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT06699849

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  • Center for Cancer and Blood Disorders, Bethesda
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT07224360

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

  • University of Maryland School of Medicine - Baltimore- Site Number : 8400041, Baltimore
Nagre-recruitPhase 3
Edad 10 hanggang 65 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT06975865

Cooperative Assessment of Late Effects for SCD Curative Therapies

  • Johns Hopkins Hospital, Baltimore
  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaral
Edad 4 hanggang 65 · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05153967

Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises

  • University of Maryland Medical Systems, Baltimore
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 24, 2025 · NCT06184126

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.